The strategic challenges facing the life sciences industry are not hugely different from those of other industries. Across the board, successful organizations must excel in such areas as product innovation and commercialization, manufacturing excellence, cost efficiency and time-to-market. However, in certain areas, life sciences stands alone, facing regulatory and marketplace pressures unheard of in most other industries.

Greater drug trial disclosure requirements, heightened public focus on product pricing and marketing activities, increased litigation coupled with soaring liability and compliance with new financial and corporate governance laws represent just a few of the external factors that have increased scrutiny and pressure on the industry. In order for life sciences organizations to achieve success, they need reach for a bar that is being set ever higher.